Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001567892-17-000020
Filing Date
2017-05-08
Accepted
2017-05-08 16:26:05
Documents
97
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnk10-q033117.htm 10-Q 1966426
2 EXHIBIT 31.1 mnkexhibit311033117.htm EX-31.1 20196
3 EXHIBIT 31.2 mnkexhibit312033117.htm EX-31.2 20240
4 EXHIBIT 32.1 mnkexhibit321033117.htm EX-32.1 7582
  Complete submission text file 0001567892-17-000020.txt   14056161

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnk-20170331.xml EX-101.INS 3882247
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnk-20170331.xsd EX-101.SCH 81843
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnk-20170331_cal.xml EX-101.CAL 112428
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnk-20170331_def.xml EX-101.DEF 611229
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnk-20170331_lab.xml EX-101.LAB 990394
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnk-20170331_pre.xml EX-101.PRE 737820
Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1229
Type: 10-Q | Act: 34 | File No.: 001-35803 | Film No.: 17822785
SIC: 2834 Pharmaceutical Preparations